Clinical Results of TerraQuant Laser
CLINICAL EFFECTS AND BENEFITS OF TERRAQUANT LASER INCLUDE:
- Stimulates the Immune System and increases 2 of the major healing enzymes by 75%
- Anti-inflammatory (speeds healing). Acts as an anti-inflammatory by reducing 7 of the 9 inflammatory enzymes by 75%
- Analgesic (pain reducing), by stimulating the cells to produce their own endorphins/natural pain killers
- Anti-edema (reduces swelling) and decreases postoperative swelling
- Normalized nervous system (Improves Nerve fiber conduction)
- Transforms living cells from an unstable state of illness into a stable, healthy state
- Improves general Blood Circulation and microcirculation, improving blood supply to the cells, muscles and tissues, which reduces the possibility of ischemic injury
- Facilitates faster tissue regeneration from injury due to accident or sports overexertion
- Non-invasive, drug-free, pain-free and surgery-free therapy that is beginning to revolutionize healing and recovery in modern medicine and sports medicine
TERRAQUANT – Defeating Pain and LOW-LEVEL LASER THERAPY (LLLT)
The TerraQuant device is the only device available today (in Australia and Worldwide) which combines together low level pulse laser radiation, and other radiations with clinical therapeutic modalities, pulsating infrared radiation, visible red light and static magnetic fields, providing their synergistic and therapeutic effects. Incorporating all these radiances in one apparatus, achieves rapid and efficient clinical effects within a relatively short time.
Musculoskeletal Pain Syndromes (Chronic and Acute)
LLLT has been shown to be effective in a variety of musculoskeletal conditions and associated pain presentations.
In Rheumatoid Arthritis , LLLT can benefit not only the pain of acute small joint inflammation but also the chronic pain . In a review article on rheumatology (3), some 18 papers were considered. All studies involved double-blind trials with LLLT in chronic rheumatoid, and reported significant improvement in pain (80% success rate in relieving pain). Upon comparing LLLT to a similar rate of pain attenuation using anti-inflammatory drugs (NSAIDs), the LLLT was free of any side-effects while 20% of patients treated with NSAIDs suffered unacceptable side-effects of medication . In another study of 170 patients with rheumatoid arthritis using LLLT (4), pain attenuation of up to 90% was noted .
CLINICAL TEST REPORT from a TOP Russian Hospital:
Ministry of International Affairs
Head of Hospital of the Russian Federation Doctor of Science
Main clinical hospital, city of Moscow
Colonel signature: S. Shets
RIKTA-04/04 (M22D) Magneto-infrared laser apparatus – Terra Quant
Main clinical hospital of the Ministry of Internal Affaires of the Russian Federation is the leading medical institution in Russia . It provides medical services for employees of the Ministry of Internal Affaires.
The hospital staff is 920 employees including 11 Doctors of Science and 38 Ph. D.
The hospital has available contemporary medical-and-diagnostic base. Clinical base consists of:
- 3 therapeutic departments;
- 2 surgical departments: surgical block and traumatologic division;
- anti-burn center;
- department of physiotherapy and rehabilitation;
- clinical-and-diagnostic laboratories;
- department of functional diagnosis.
All the department are equipped with up-to-date medical and diagnostic equipment.
The clinical test has been contacted at the base .of traumatologic division (60 beds).
Period of the clinical test: February-October 2000.
The patients of the following nosologies have been selected for the test:
1) scapulohumeral periarthritis;
2) post traumatic injury of joints.
Patients of each nosology have been divided into 3 groups:
- Patients of group I underwent to traditional pharmocologic, surgical and physiotherapy treatment.
- Patients of group II underwent to course of quantum therapy with use of RIKTA-04/4 (M22D)/Terra Quant apparatus.
- Group III consisted of patients who underwent to placebo treatment by RIKTA-04/4 (M22D)/Terra Quant apparatus imitator that was outwardly the same as real apparatus but hasn’t any influence upon the patient.
The patients of group II were treated in accordance with the methods which have been developed and represented by JSC “MILTA-PKP GIT” and applied as the user’s manual.
Patients’ characteristics
Scapulohumeral periarthritis
Total number of patients – 90, including 72 men and 18 women
Patients’ age: 20-30 years old – 12 patients
- 31-40 years old – 24 patients
- 41-50 years old – 24 patients
- 61-70 years old – 10 patients
- 71 years and older – 9 patients
Medical history of patients: less than 1 year – 7 patients
- less than 2 year – 9 patients
- less than 3 year – 14 patients
- less than 4 year – 22 patients
- less than 5 year – 13 patients
- 6 years and more – 11 patients
The treatment course consisted of 12-15 sessions of daily procedures.
The positive effect criteria were as follows: cupping of pain syndrome, recovery of locomotory function, positive dynamic of roentgenologic examination.
Posttraumatic injury of joints
Total number of patients – 90, including 81 men and 9 women
Patients’ age: 20-30 years old – 12 patients
- 31-40 years old – 28 patients
- 41-50 years old – 24 patients
- 51-60 years old – 10 patients
- 61 years and older – 9 patients
Medical history of patients: less than 1 year – 28 patients
- less than 2 year – 34 patients
- less than 3 year – 4 patients
- less than 4 year – 8 patients
- 5 years and more – 6 patients
The treatment course consisted of 12-15 procedures.
The positive effect criteria were as follows: cupping of pain syndrome, recovery of locomotory function, positive dynamic of roentgenologic examination.
Results of treatment in all three groups of patients are represented in table 1.
Table 1
Nosology Number of patients Treatment results
Total Group Group I Group II Group III
I II III
Scapulohumeral periarthritis
90, 40, 50, 0
Positive effect – 63%. Positive effect -86%. Drug dose – 27% less.
Treatment period – 6 days shorter
Posttraumatic injury of joints
90, 45, 40, 5
Positive effect – 56%. Positive effect -81%. Drug dose – 17% less.
Treatment period – 2 days shorter
Positive effect – 17%
____________________________________________________________
Evaluation of treatment with the Terraquant device for shoulder pain:
A report by, Dr. Gabi Zeilig, MD
Department of Neurological Rehabilitaion. The Chaim Sheba Medical Center, Tel Hashomer, Israel
The purpose of this study is to test the efficiency of the TerraQuant device on shoulder pain resulting from inflammation (OA, Tendonitis, Bursitis) and muscle trigger points.
Background:
The Terraquant is a unique device, which combines low level pulse laser therapy (LLLT), pulsating infrared radiation, visible red light and static magnetic fields, providing their synergistic therapeutic effect. The primary effect of LLLT is a local time response to direct irradiation and includes vasodilatation with increased circulatory flow; increased macrophages and fibroblast activity and improved metabolic function of depressed or damaged cells. Delayed response consists of a systemic effect caused by circulating photoproducts of irradiation in the blood and lymphatic systems. Increased plasma concentration of certain types of prostaglandins and endorphins have all be identified and play a major role in the mechnism of pain attenuation.
LLLT has been shown to be safe and effective (1,2,3,4)
The Method:
Experimental design:
The design is an A-B design, (pre-test post-test design) with a control group. The study is a double blind using two indentical unmarked TerraQuant devices, which one of is a demo device. A sample of convenience according to set criteria’s will be used. The patients will be randomly assigned to two groups. The experimental group received both conventional therapy and the Terra Quant treatment from a demo device.
Subjects:
Twenty subjects with moderate to severe shoulder pain were recruited within a period of 1 month from the one of the departments of neurological rehabilitation affiliated to theTel Aviv University..
Candidantes were either inpatients or outpatients and they were selected after evaluation of symptoms based on these criterias:
1. All candidates must present shoulder pain of a musculoskeletal benign nature such as inflammation, arthritis, muscle trigger point overuse, impingement, and degenerative changes.
2. All subjects must be referred by a Physician after a full physical evaluation including radiography.
3. Onsest of symptoms should be between 2 weeks and 3 months.
4. Subjects should not have any additional medical conditions that will produce confounding results. The subjects perceptual and cognitive status should be preserved.
5. Subjects should be medically stable. Patients with aprevious myocardial infarctions or pacemakers are excluded from the study.
6. Subjects will have to sign an informed consent.
Procedure:
Subjects have been evaluated by a Physician and by a Physical therapist before the beginning of the treatment. Evaluation of Active Range of Motion of the shoulder joint (GHJ) using a goniometer.
Evalution of muscle strength according to MMT.
Evaluation of pain using the Visual Analog Scale (VAS).
A total of 8 treatment procedures preformed every other day. After the end of the treatment the subjects have been evaluated again by the same PT and MD to maintain inter-rater reliability.
Follow up was performed 1month after termination of treatment.
Conventional therapy:
A physical therapy protocol to treatment accoding to the diagnosis may include: manual therapy, soft tissue manipulation, AROM and strenthening but should not include modalities to prevent confounding factors.
Average treatment time: 30 min.
TerraQuant treatment: According to the protocol; 5 min per zone, Frequency: 50 HZ
Results:
A total of 18 patients completed the study. There were 12 individuals with spinal cord injury (SCI), and 6 with hemiplegia following CVA. Among the SCI individuals, there were four with paraplegia and eight with tetraplegia. The average age of the participants was 46 + 15.5. 15 were males and 3 females. 12 of the total group had the VAS evaluation done before and after the termination of the treatment.
The device A was used in 8 patients; B in 10 patients.
There was a clear improvement in shoulder ROM in the group treated with the device B (p=0.001).
The improvement in VAS scale was visible in the group B, yet did not reach a statistical significance (p-0.1).
Conclusions:
Terraquant treatment proved to be significantly more efficient than placebo in patients with decreased shoulder ROM, and more efficient than placebo in patients with shoulder pain. No side-effects were observed.
The positive outcome of this study as well as the lack of side-effects suggests that Terraquant therapy may be an effective and economical tool in the treatment of pain and reduced range of motion in people with shoulder problems following CVA or SCI.
Larger and randomized trials are needed in order to confirm this preliminary data.
1. Simunovic Z. Low level laser therapy with trigger points technique: a clinical study on 243 patients.J Clin Laser Med Surg. 14(4): 163-167. 1996.
2. Ozdemir F et al. The clinical efficacy of low power laser therapy on pain and function in cervical osteoarthritis. Clin Rheumatol. 20(3): 181-184. 2001.
3. Lewith GT, Machin D. A randomised trial to evaluate the effect of infra-red stimulation of local trigger points versus placebo, on pain cused by cervical osteoarthritis. Acupunct Electrother Res. 6(4): 277-284, 1981.
4. England et al. Low power laser therapy of shoulder tendinitis. Scan J Rheumatol. 18(6):427-31, 1989
Tags: Blog/News · Cold Laser Clinical Studies · Cold Laser Information & Low Level Laser Articles · Cold Laser Medical Studies Data · Cold Laser Therapy Education · Cold Lasers · Health and Light News · TerraQuant
